London, Jan. 30, 2024 (GLOBE NEWSWIRE) — January 30, 2024, London, UK – OPEN Health has launched OPEN X Health, a new practice focused on providing data-driven creativity to the pharmaceutical industry. OPEN X Health (OPEN X) launches after two years of investment and growth in the creative communications offering from OPEN Health. OPEN Health acquired […]
English
AccessPay Increases Coverage of Fraud & Error Prevention Suite With Embedded Confirmation of Payee and Sanctions Screening
New capabilities help corporates de-risk their payment cycle within the AccessPay platformMANCHESTER, UK / ACCESSWIRE / January 30, 2024 / AccessPay, the leading provider of bank integration, today announced the addition of Confirmation of Payee (CoP) …
MorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability
Preliminary 2023 Monjuvi U.S. net product sales of US$ 92.0 million (€ 85.0 million) and preliminary gross margin for Monjuvi U.S. net product sales of 69%Anticipated 2024 Monjuvi U.S. net product sales in the range of US$ 80 to 95 millionAnticipated 2…
Troy Minerals Announces Upcoming Drill Program at Its High Grade Ree Lac Jacques Project in Quebec
VANCOUVER, BC / ACCESSWIRE / January 30, 2024 / Troy MineralsInc. (“Troy” or the “Company”) (CSE:TROY)(OTCQB:TROYF)(FSE:VJ3) is pleased to announce details of the planned 2024 winter/spring drill program at the Lac Jacques rare eart…
EOS INC. Estimates Over $40 Million in Tax-Inclusive Sales for Q1 2024
HONG KONG / ACCESSWIRE / January 30, 2024 / EOS INC. is a leading global resource service provider of biotechnology and products. Dedicating to the global regenerative medicine technology and biotechnology product development service provider, so that …
Nebeus Secures €250M Institutional Funding for Its Crypto Loan Offering
LONDON, ENGLAND / ACCESSWIRE / January 30, 2024 / Nebeus, a pioneering company in the crypto loans landscape since 2014, announces the launch of its crypto-backed loan programme with €250 million in liquidity. Tailored for both corporate and consumer c…
MindBio Therapeutics Nears Completion of Landmark Phase 2a LSD Microdosing (MB22001) Clinical Trial in Depressed Patients
VANCOUVER, BC / ACCESSWIRE / January 30, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the “Company” or “MindBio”), announces it is nearing the completion of its Phase 2a clinical trial using MB22001 in patients with…
LPSN DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages LivePerson, Inc. Investors with Losses to Secure Counsel Before Important January 30 Deadline in Securities Class Action – LPSN
NEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LivePerson, Inc. (NASDAQ: LPSN) between May 10, 2022 and March 16, 2023, both dates inclusive (the “Class Period”), of the important January 30, 2024 lead plaintiff deadline. SO WHAT: If you purchased […]